ValGenesis, Inc. is pleased to announce that a global Life Science company with integrated services and product offering has chosen ValGenesis Validation Lifecycle Management System to manage their corporate validation lifecycle process in a 100% paperless mode.
ValGenesis, Inc., the market leader in Enterprise Validation Lifecycle Management Solutions (VLMS) is pleased to announce that a global Life Science company with integrated services and product offering has chosen ValGenesis Validation Lifecycle Management System to manage their corporate validation lifecycle process in a 100% paperless mode.
Ranked in the top 25 listed companies in the Fortune 500 Global, this company provides customized solutions to hospitals, health systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices. It has nearly 100 years of experience, with approximately 50,000 employees in nearly 60 countries providing clinically-proven medical products, pharmaceuticals, and cost-effective solutions. Their solutions enhance supply chain efficiency and improve patient management by connecting hospital, patients, providers, payers, and manufacturers to achieve more integrated care.
In recognizing that traditional, manual, paper-based validation processes are costly and inefficient, this company sought an electronic, paperless, cloud-based, SaaS solution to meet their needs. They sought to identify a robust validation management software solution to replace their in-house developed system. Upon completion of their search and evaluation, they determined that ValGenesis offered a significant improvement to their current validation process. The opportunity to increase efficiency, reduce validation lifecycle times, improve regulatory compliance and to gain a holistic view of site validation status, made ValGenesis their system of choice. The initial rollout of the ValGenesis solution seeks to apply it for managing their global CSV needs. Subsequently, the company plans to extend its use of the ValGenesis tools for equipment, cleaning, and other validation activities.
“For the past twelve years, ValGenesis has been providing an enterprise validation lifecycle management software solution to the Life Science industry. We are delighted to have this Fortune 500 company implement the ValGenesis VLMS system to meet their validation management requirements,” said Narayan Raj, Vice President of ValGenesis Inc. ValGenesis is committed and continues to build its leadership position and to offer solutions such as ValGenesis VLMS that are being recognized as the de-facto standard on how a Paperless Validation Lifecycle Management system can improve quality assurance and regulatory compliance for global life sciences companies.
About ValGenesis
ValGenesis, Inc. is the inventor of an innovative software platform serving as the foundation for managing compliance-based validation activities in Life Sciences companies. ValGenesis, Inc. provides the first enterprise application to manage the corporate validation lifecycle process. As the only system for managing validation execution and approval 100% electronically, ValGenesis was selected by an industry peer review committee to receive the Parenteral Drug Association (PDA) New Innovative Technology Award. The solution is fully compliant with U.S. FDA 21 CFR Part 11 and Annex 11 requirements. For more information, visit www.valgenesis.com.
Media contact:
Shanti Mulyadi
510-445-0505
SOURCE ValGenesis
